CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the effectiveness of intermittent intensified androgen deprivation treatment for metastatic prostate cancer compared to continuous treatment. The goal is to enhance patient quality of life while maintaining oncological benefits, potentially establishing a new standard of care.
Prostate Cancer is the most common cancer in European men.
Despite dramatic improvements in early diagnostic and local treatment, one out of five prostate cancer patients will die from their disease.
Despite progress in the past years, it remains critical to improve on the present strategy for advanced and metastatic prostate cancer.
Within the proposed project, we will evaluate whether intermittent intensified androgen deprivation treatment (iADT) in metastatic prostate cancer is not inferior t…
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Hungary, Budapest
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
